Ke-Ji Chen
Overview
Explore the profile of Ke-Ji Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
240
Citations
1189
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Z, Xing W, Liu H, Shang J, Li A, Zhou Q, et al.
Chin J Integr Med
. 2024 Dec;
31(3):206-214.
PMID: 39617867
Objective: To evaluate the immediate effect of Kuanxiong Aerosol (KXA) on perioperative coronary microcirculation in patients with unstable angina (UA) suffering from elective percutaneous coronary intervention (PCI). Methods: From February...
2.
Long L, Tan L, Xu F, Yang W, Li H, Liu J, et al.
Chin J Integr Med
. 2024 Sep;
PMID: 39243318
Objective: To assess the efficacy of Qingda Granule (QDG) in ameliorating hypertension-induced cardiac damage and investigate the underlying mechanisms involved. Methods: Twenty spontaneously hypertensive rats (SHRs) were used to develope...
3.
Advance on Chinese Medicine for Hypertensive Renal Damage: Focus on the Complex Molecular Mechanisms
Lu Y, Xie X, Xin Q, Yuan R, Miao Y, Cong W, et al.
Chin J Integr Med
. 2024 Jul;
30(10):938-948.
PMID: 38958884
Hypertensive renal damage (HRD) is a major cause of end-stage renal disease. Among the causes of end-stage renal disease, HRD accounts for nearly 34% of the total number of cases....
4.
Qu H, Shen A, Yang K, Huang M, Li H, Yang W, et al.
Pharmacol Res
. 2024 Jan;
200:107052.
PMID: 38181857
Background: The efficacy and safety of Qingda granule (QDG) in managing blood pressure (BP) among grade 1 hypertensive patients with low-moderate risk remain uncertain. Methods: In the randomized, double-blind, double...
5.
Wang Z, Wu Y, Gao Y, Qian J, Liu L, Guo Y, et al.
BMC Cardiovasc Disord
. 2023 May;
23(1):227.
PMID: 37127585
Background: Familial hypercholesterolemia (FH) leads to high plasma low-density lipoprotein cholesterol (LDL-C) levels and early cardiovascular morbidity and mortality. We treated a pair of siblings with FH. The cardiovascular manifestations...
6.
Long L, Chu J, Qu H, Yang Q, Lu Y, Fu C, et al.
Trials
. 2023 Jan;
24(1):1.
PMID: 36588157
Background: Numerous pre-clinical studies showed that Qingda granule (QDG) was effective in treating hypertension. This study aims to evaluate the efficacy and safety of QDG in reducing blood pressure among...
7.
Wang C, Huan N, Wang P, Geng Q, Ma W, Ma L, et al.
Chin J Integr Med
. 2022 Oct;
29(3):195-204.
PMID: 36301456
Objective: To assess the efficacy and safety of Guanxin Danshen Dripping Pills (GXDS) in the treatment of depression or anxiety in patients with coronary heart disease (CHD) after percutaneous coronary...
8.
Wang L, Zhou B, Li Y, Jiang Q, Cong W, Chen K, et al.
Neural Regen Res
. 2022 Jul;
18(1):226-232.
PMID: 35799547
Previous studies have shown that berberine has neuroprotective effects against Alzheimer's disease, including antagonizing tau phosphorylation, and inhibiting acetylcholinesterase activity and neural cell apoptosis. However, its low bioavailability and adverse...
9.
Li Q, Chang M, Wang X, Wang A, Liu Q, Wang T, et al.
Sci Rep
. 2022 Apr;
12(1):6552.
PMID: 35449366
Acute myocardial infarction (AMI) is one of the main causes of death in the world, and the incidence of AMI is increasing in the young population. Drug-coated balloon (DCB) has...
10.
Ma X, Duan W, Zhang Y, Gao J, Guan B, Chen K, et al.
Chin J Integr Med
. 2021 Sep;
27(11):803-810.
PMID: 34532749
Objective: To investigate the combined anti-inflammatory effect of activating blood circulation and detoxifying Chinese medicines in unstable angina (UA) patients. Methods: This study was an open-labeled, randomized controlled trial conducted...